Artificial Blood Cells and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Artificial Blood Cells Market Definition
1.2 Market Segments
1.2.1 Market by Source
1.2.2 Market by Application
1.3 Global Artificial Blood Cells Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Artificial Blood Cells Overall Market Size
2.1 Global Artificial Blood Cells Market Size: 2021 VS 2028
2.2 Global Artificial Blood Cells Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Artificial Blood Cells Sales: 2017-2028
3 Company Landscape
3.1 Top Artificial Blood Cells Players in Global Market
3.2 Top Global Artificial Blood Cells Companies Ranked by Revenue
3.3 Global Artificial Blood Cells Revenue by Companies
3.4 Global Artificial Blood Cells Sales by Companies
3.5 Global Artificial Blood Cells Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Artificial Blood Cells Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Artificial Blood Cells Product Type
3.8 Tier 1, Tier 2 and Tier 3 Artificial Blood Cells Players in Global Market
3.8.1 List of Global Tier 1 Artificial Blood Cells Companies
3.8.2 List of Global Tier 2 and Tier 3 Artificial Blood Cells Companies
4 Sights by Product
4.1 Overview
4.1.1 By Source - Global Artificial Blood Cells Market Size Markets, 2021 & 2028
4.1.2 Animal Hemoglobin
4.1.3 Human Hemoglobin
4.1.4 Stem Cell
4.1.5 Others
4.2 By Source - Global Artificial Blood Cells Revenue & Forecasts
4.2.1 By Source - Global Artificial Blood Cells Revenue, 2017-2022
4.2.2 By Source - Global Artificial Blood Cells Revenue, 2023-2028
4.2.3 By Source - Global Artificial Blood Cells Revenue Market Share, 2017-2028
4.3 By Source - Global Artificial Blood Cells Sales & Forecasts
4.3.1 By Source - Global Artificial Blood Cells Sales, 2017-2022
4.3.2 By Source - Global Artificial Blood Cells Sales, 2023-2028
4.3.3 By Source - Global Artificial Blood Cells Sales Market Share, 2017-2028
4.4 By Source - Global Artificial Blood Cells Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Artificial Blood Cells Market Size, 2021 & 2028
5.1.2 Cardiovascular Diseases
5.1.3 Anemia
5.1.4 Organ Transplant
5.1.5 Others
5.2 By Application - Global Artificial Blood Cells Revenue & Forecasts
5.2.1 By Application - Global Artificial Blood Cells Revenue, 2017-2022
5.2.2 By Application - Global Artificial Blood Cells Revenue, 2023-2028
5.2.3 By Application - Global Artificial Blood Cells Revenue Market Share, 2017-2028
5.3 By Application - Global Artificial Blood Cells Sales & Forecasts
5.3.1 By Application - Global Artificial Blood Cells Sales, 2017-2022
5.3.2 By Application - Global Artificial Blood Cells Sales, 2023-2028
5.3.3 By Application - Global Artificial Blood Cells Sales Market Share, 2017-2028
5.4 By Application - Global Artificial Blood Cells Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Artificial Blood Cells Market Size, 2021 & 2028
6.2 By Region - Global Artificial Blood Cells Revenue & Forecasts
6.2.1 By Region - Global Artificial Blood Cells Revenue, 2017-2022
6.2.2 By Region - Global Artificial Blood Cells Revenue, 2023-2028
6.2.3 By Region - Global Artificial Blood Cells Revenue Market Share, 2017-2028
6.3 By Region - Global Artificial Blood Cells Sales & Forecasts
6.3.1 By Region - Global Artificial Blood Cells Sales, 2017-2022
6.3.2 By Region - Global Artificial Blood Cells Sales, 2023-2028
6.3.3 By Region - Global Artificial Blood Cells Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Artificial Blood Cells Revenue, 2017-2028
6.4.2 By Country - North America Artificial Blood Cells Sales, 2017-2028
6.4.3 US Artificial Blood Cells Market Size, 2017-2028
6.4.4 Canada Artificial Blood Cells Market Size, 2017-2028
6.4.5 Mexico Artificial Blood Cells Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Artificial Blood Cells Revenue, 2017-2028
6.5.2 By Country - Europe Artificial Blood Cells Sales, 2017-2028
6.5.3 Germany Artificial Blood Cells Market Size, 2017-2028
6.5.4 France Artificial Blood Cells Market Size, 2017-2028
6.5.5 U.K. Artificial Blood Cells Market Size, 2017-2028
6.5.6 Italy Artificial Blood Cells Market Size, 2017-2028
6.5.7 Russia Artificial Blood Cells Market Size, 2017-2028
6.5.8 Nordic Countries Artificial Blood Cells Market Size, 2017-2028
6.5.9 Benelux Artificial Blood Cells Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Artificial Blood Cells Revenue, 2017-2028
6.6.2 By Region - Asia Artificial Blood Cells Sales, 2017-2028
6.6.3 China Artificial Blood Cells Market Size, 2017-2028
6.6.4 Japan Artificial Blood Cells Market Size, 2017-2028
6.6.5 South Korea Artificial Blood Cells Market Size, 2017-2028
6.6.6 Southeast Asia Artificial Blood Cells Market Size, 2017-2028
6.6.7 India Artificial Blood Cells Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Artificial Blood Cells Revenue, 2017-2028
6.7.2 By Country - South America Artificial Blood Cells Sales, 2017-2028
6.7.3 Brazil Artificial Blood Cells Market Size, 2017-2028
6.7.4 Argentina Artificial Blood Cells Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Artificial Blood Cells Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Artificial Blood Cells Sales, 2017-2028
6.8.3 Turkey Artificial Blood Cells Market Size, 2017-2028
6.8.4 Israel Artificial Blood Cells Market Size, 2017-2028
6.8.5 Saudi Arabia Artificial Blood Cells Market Size, 2017-2028
6.8.6 UAE Artificial Blood Cells Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Dextro-Sang Corporation
7.1.1 Dextro-Sang Corporation Corporate Summary
7.1.2 Dextro-Sang Corporation Business Overview
7.1.3 Dextro-Sang Corporation Artificial Blood Cells Major Product Offerings
7.1.4 Dextro-Sang Corporation Artificial Blood Cells Sales and Revenue in Global (2017-2022)
7.1.5 Dextro-Sang Corporation Key News
7.2 BioPure Corporation
7.2.1 BioPure Corporation Corporate Summary
7.2.2 BioPure Corporation Business Overview
7.2.3 BioPure Corporation Artificial Blood Cells Major Product Offerings
7.2.4 BioPure Corporation Artificial Blood Cells Sales and Revenue in Global (2017-2022)
7.2.5 BioPure Corporation Key News
7.3 Sangart
7.3.1 Sangart Corporate Summary
7.3.2 Sangart Business Overview
7.3.3 Sangart Artificial Blood Cells Major Product Offerings
7.3.4 Sangart Artificial Blood Cells Sales and Revenue in Global (2017-2022)
7.3.5 Sangart Key News
7.4 Northfield Laboratories
7.4.1 Northfield Laboratories Corporate Summary
7.4.2 Northfield Laboratories Business Overview
7.4.3 Northfield Laboratories Artificial Blood Cells Major Product Offerings
7.4.4 Northfield Laboratories Artificial Blood Cells Sales and Revenue in Global (2017-2022)
7.4.5 Northfield Laboratories Key News
7.5 Baxter International
7.5.1 Baxter International Corporate Summary
7.5.2 Baxter International Business Overview
7.5.3 Baxter International Artificial Blood Cells Major Product Offerings
7.5.4 Baxter International Artificial Blood Cells Sales and Revenue in Global (2017-2022)
7.5.5 Baxter International Key News
7.6 Dentritech
7.6.1 Dentritech Corporate Summary
7.6.2 Dentritech Business Overview
7.6.3 Dentritech Artificial Blood Cells Major Product Offerings
7.6.4 Dentritech Artificial Blood Cells Sales and Revenue in Global (2017-2022)
7.6.5 Dentritech Key News
7.7 FluorO2 Therapeutics
7.7.1 FluorO2 Therapeutics Corporate Summary
7.7.2 FluorO2 Therapeutics Business Overview
7.7.3 FluorO2 Therapeutics Artificial Blood Cells Major Product Offerings
7.7.4 FluorO2 Therapeutics Artificial Blood Cells Sales and Revenue in Global (2017-2022)
7.7.5 FluorO2 Therapeutics Key News
7.8 Nuvox Pharma
7.8.1 Nuvox Pharma Corporate Summary
7.8.2 Nuvox Pharma Business Overview
7.8.3 Nuvox Pharma Artificial Blood Cells Major Product Offerings
7.8.4 Nuvox Pharma Artificial Blood Cells Sales and Revenue in Global (2017-2022)
7.8.5 Nuvox Pharma Key News
7.9 Alpha Therapeutic Corporation
7.9.1 Alpha Therapeutic Corporation Corporate Summary
7.9.2 Alpha Therapeutic Corporation Business Overview
7.9.3 Alpha Therapeutic Corporation Artificial Blood Cells Major Product Offerings
7.9.4 Alpha Therapeutic Corporation Artificial Blood Cells Sales and Revenue in Global (2017-2022)
7.9.5 Alpha Therapeutic Corporation Key News
7.10 HemoBioTech
7.10.1 HemoBioTech Corporate Summary
7.10.2 HemoBioTech Business Overview
7.10.3 HemoBioTech Artificial Blood Cells Major Product Offerings
7.10.4 HemoBioTech Artificial Blood Cells Sales and Revenue in Global (2017-2022)
7.10.5 HemoBioTech Key News
8 Global Artificial Blood Cells Production Capacity, Analysis
8.1 Global Artificial Blood Cells Production Capacity, 2017-2028
8.2 Artificial Blood Cells Production Capacity of Key Manufacturers in Global Market
8.3 Global Artificial Blood Cells Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Artificial Blood Cells Supply Chain Analysis
10.1 Artificial Blood Cells Industry Value Chain
10.2 Artificial Blood Cells Upstream Market
10.3 Artificial Blood Cells Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Artificial Blood Cells Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Artificial Blood Cells in Global Market
Table 2. Top Artificial Blood Cells Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Artificial Blood Cells Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Artificial Blood Cells Revenue Share by Companies, 2017-2022
Table 5. Global Artificial Blood Cells Sales by Companies, (K Units), 2017-2022
Table 6. Global Artificial Blood Cells Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Artificial Blood Cells Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Artificial Blood Cells Product Type
Table 9. List of Global Tier 1 Artificial Blood Cells Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Artificial Blood Cells Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Source ? Global Artificial Blood Cells Revenue, (US$, Mn), 2021 & 2028
Table 12. By Source - Global Artificial Blood Cells Revenue (US$, Mn), 2017-2022
Table 13. By Source - Global Artificial Blood Cells Revenue (US$, Mn), 2023-2028
Table 14. By Source - Global Artificial Blood Cells Sales (K Units), 2017-2022
Table 15. By Source - Global Artificial Blood Cells Sales (K Units), 2023-2028
Table 16. By Application ? Global Artificial Blood Cells Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Artificial Blood Cells Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Artificial Blood Cells Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Artificial Blood Cells Sales (K Units), 2017-2022
Table 20. By Application - Global Artificial Blood Cells Sales (K Units), 2023-2028
Table 21. By Region ? Global Artificial Blood Cells Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Artificial Blood Cells Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Artificial Blood Cells Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Artificial Blood Cells Sales (K Units), 2017-2022
Table 25. By Region - Global Artificial Blood Cells Sales (K Units), 2023-2028
Table 26. By Country - North America Artificial Blood Cells Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Artificial Blood Cells Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Artificial Blood Cells Sales, (K Units), 2017-2022
Table 29. By Country - North America Artificial Blood Cells Sales, (K Units), 2023-2028
Table 30. By Country - Europe Artificial Blood Cells Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Artificial Blood Cells Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Artificial Blood Cells Sales, (K Units), 2017-2022
Table 33. By Country - Europe Artificial Blood Cells Sales, (K Units), 2023-2028
Table 34. By Region - Asia Artificial Blood Cells Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Artificial Blood Cells Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Artificial Blood Cells Sales, (K Units), 2017-2022
Table 37. By Region - Asia Artificial Blood Cells Sales, (K Units), 2023-2028
Table 38. By Country - South America Artificial Blood Cells Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Artificial Blood Cells Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Artificial Blood Cells Sales, (K Units), 2017-2022
Table 41. By Country - South America Artificial Blood Cells Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Artificial Blood Cells Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Artificial Blood Cells Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Artificial Blood Cells Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Artificial Blood Cells Sales, (K Units), 2023-2028
Table 46. Dextro-Sang Corporation Corporate Summary
Table 47. Dextro-Sang Corporation Artificial Blood Cells Product Offerings
Table 48. Dextro-Sang Corporation Artificial Blood Cells Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. BioPure Corporation Corporate Summary
Table 50. BioPure Corporation Artificial Blood Cells Product Offerings
Table 51. BioPure Corporation Artificial Blood Cells Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Sangart Corporate Summary
Table 53. Sangart Artificial Blood Cells Product Offerings
Table 54. Sangart Artificial Blood Cells Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Northfield Laboratories Corporate Summary
Table 56. Northfield Laboratories Artificial Blood Cells Product Offerings
Table 57. Northfield Laboratories Artificial Blood Cells Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Baxter International Corporate Summary
Table 59. Baxter International Artificial Blood Cells Product Offerings
Table 60. Baxter International Artificial Blood Cells Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Dentritech Corporate Summary
Table 62. Dentritech Artificial Blood Cells Product Offerings
Table 63. Dentritech Artificial Blood Cells Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. FluorO2 Therapeutics Corporate Summary
Table 65. FluorO2 Therapeutics Artificial Blood Cells Product Offerings
Table 66. FluorO2 Therapeutics Artificial Blood Cells Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Nuvox Pharma Corporate Summary
Table 68. Nuvox Pharma Artificial Blood Cells Product Offerings
Table 69. Nuvox Pharma Artificial Blood Cells Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Alpha Therapeutic Corporation Corporate Summary
Table 71. Alpha Therapeutic Corporation Artificial Blood Cells Product Offerings
Table 72. Alpha Therapeutic Corporation Artificial Blood Cells Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. HemoBioTech Corporate Summary
Table 74. HemoBioTech Artificial Blood Cells Product Offerings
Table 75. HemoBioTech Artificial Blood Cells Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Artificial Blood Cells Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 77. Global Artificial Blood Cells Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Artificial Blood Cells Production by Region, 2017-2022 (K Units)
Table 79. Global Artificial Blood Cells Production by Region, 2023-2028 (K Units)
Table 80. Artificial Blood Cells Market Opportunities & Trends in Global Market
Table 81. Artificial Blood Cells Market Drivers in Global Market
Table 82. Artificial Blood Cells Market Restraints in Global Market
Table 83. Artificial Blood Cells Raw Materials
Table 84. Artificial Blood Cells Raw Materials Suppliers in Global Market
Table 85. Typical Artificial Blood Cells Downstream
Table 86. Artificial Blood Cells Downstream Clients in Global Market
Table 87. Artificial Blood Cells Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Artificial Blood Cells Segment by Source
Figure 2. Artificial Blood Cells Segment by Application
Figure 3. Global Artificial Blood Cells Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Artificial Blood Cells Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Artificial Blood Cells Revenue, 2017-2028 (US$, Mn)
Figure 7. Artificial Blood Cells Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Artificial Blood Cells Revenue in 2021
Figure 9. By Source - Global Artificial Blood Cells Sales Market Share, 2017-2028
Figure 10. By Source - Global Artificial Blood Cells Revenue Market Share, 2017-2028
Figure 11. By Source - Global Artificial Blood Cells Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Artificial Blood Cells Sales Market Share, 2017-2028
Figure 13. By Application - Global Artificial Blood Cells Revenue Market Share, 2017-2028
Figure 14. By Application - Global Artificial Blood Cells Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Artificial Blood Cells Sales Market Share, 2017-2028
Figure 16. By Region - Global Artificial Blood Cells Revenue Market Share, 2017-2028
Figure 17. By Country - North America Artificial Blood Cells Revenue Market Share, 2017-2028
Figure 18. By Country - North America Artificial Blood Cells Sales Market Share, 2017-2028
Figure 19. US Artificial Blood Cells Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Artificial Blood Cells Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Artificial Blood Cells Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Artificial Blood Cells Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Artificial Blood Cells Sales Market Share, 2017-2028
Figure 24. Germany Artificial Blood Cells Revenue, (US$, Mn), 2017-2028
Figure 25. France Artificial Blood Cells Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Artificial Blood Cells Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Artificial Blood Cells Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Artificial Blood Cells Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Artificial Blood Cells Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Artificial Blood Cells Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Artificial Blood Cells Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Artificial Blood Cells Sales Market Share, 2017-2028
Figure 33. China Artificial Blood Cells Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Artificial Blood Cells Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Artificial Blood Cells Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Artificial Blood Cells Revenue, (US$, Mn), 2017-2028
Figure 37. India Artificial Blood Cells Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Artificial Blood Cells Revenue Market Share, 2017-2028
Figure 39. By Country - South America Artificial Blood Cells Sales Market Share, 2017-2028
Figure 40. Brazil Artificial Blood Cells Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Artificial Blood Cells Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Artificial Blood Cells Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Artificial Blood Cells Sales Market Share, 2017-2028
Figure 44. Turkey Artificial Blood Cells Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Artificial Blood Cells Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Artificial Blood Cells Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Artificial Blood Cells Revenue, (US$, Mn), 2017-2028
Figure 48. Global Artificial Blood Cells Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Artificial Blood Cells by Region, 2021 VS 2028
Figure 50. Artificial Blood Cells Industry Value Chain
Figure 51. Marketing Channels
